The Cooked Meat Carcinogen 2‑Amino-1-methyl-6-phenylimidazo[4,5‑b]pyridine Hair Dosimeter, DNA Adductomics Discovery, and Associations with Prostate Cancer Pathology Biomarkers

Well-done cooked red meat consumption is linked to aggressive prostate cancer (PC) risk. Identifying mutation-inducing DNA adducts in the prostate genome can advance our understanding of chemicals in meat that may contribute to PC. 2-Amino-1-methyl-6-phenylimidazo­[4,5-b]­pyridine (PhIP), a heterocy...

Full description

Saved in:
Bibliographic Details
Published inChemical research in toxicology Vol. 35; no. 5; pp. 703 - 730
Main Authors Guo, Jingshu, Koopmeiners, Joseph S., Walmsley, Scott J., Villalta, Peter W., Yao, Lihua, Murugan, Paari, Tejpaul, Resha, Weight, Christopher J., Turesky, Robert J.
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 16.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Well-done cooked red meat consumption is linked to aggressive prostate cancer (PC) risk. Identifying mutation-inducing DNA adducts in the prostate genome can advance our understanding of chemicals in meat that may contribute to PC. 2-Amino-1-methyl-6-phenylimidazo­[4,5-b]­pyridine (PhIP), a heterocyclic aromatic amine (HAA) formed in cooked meat, is a potential human prostate carcinogen. PhIP was measured in the hair of PC patients undergoing prostatectomy, bladder cancer patients under treatment for cystoprostatectomy, and patients treated for benign prostatic hyperplasia (BPH). PhIP hair levels were above the quantification limit in 123 of 205 subjects. When dichotomizing prostate pathology biomarkers, the geometric mean PhIP hair levels were higher in patients with intermediate and elevated-risk prostate-specific antigen values than lower-risk values <4 ng/mL (p = 0.03). PhIP hair levels were also higher in patients with intermediate and high-risk Gleason scores ≥7 compared to lower-risk Gleason score 6 and BPH patients (p = 0.02). PC patients undergoing prostatectomy had higher PhIP hair levels than cystoprostatectomy or BPH patients (p = 0.02). PhIP-DNA adducts were detected in 9.4% of the patients assayed; however, DNA adducts of other carcinogenic HAAs, and benzo­[a]­pyrene formed in cooked meat, were not detected. Prostate specimens were also screened for 10 oxidative stress-associated lipid peroxidation (LPO) DNA adducts. Acrolein 1,N 2-propano-2′-deoxyguanosine adducts were detected in 54.5% of the patients; other LPO adducts were infrequently detected. Acrolein adducts were not associated with prostate pathology biomarkers, although DNA adductomic profiles differed between PC patients with low and high-grade Gleason scores. Many DNA adducts are of unknown origin; however, dG adducts of formaldehyde and a series of purported 4-hydroxy-2-alkenals were detected at higher abundance in a subset of patients with elevated Gleason scores. The PhIP hair biomarker and DNA adductomics data support the paradigm of well-done cooked meat and oxidative stress in aggressive PC risk.
Bibliography:Christopher J. Weight – Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland 44125, Ohio, and Case Comprehensive Cancer Center, Cleveland 44106, Ohio
Scott J. Walmsley – Masonic Cancer Center and Institute of Health Informatics, University of Minnesota, Minneapolis 55455, Minnesota
355 River Oaks Parkway, San Jose, CA 95134
The manuscript was written through the contributions of all authors. All authors have approved the final version of the manuscript
Jingshu Guo – Masonic Cancer Center and Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis 55455, Minnesota, United States; current address: Senior Product Applications Specialist, Clinical Research and Toxicology, Chromatography and Mass Spectrometry Division, Thermo Fisher Scientific
AUTHOR INFORMATION
Joseph S. Koopmeiners - Masonic Cancer Center and Division of Biostatistics, University of Minnesota, Minneapolis 55455, Minnesota, United States
Peter W. Villalta – Masonic Cancer Center and Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis 55455, Minnesota
Resha Tejpaul - Department of Urology University of Minnesota, Minneapolis 55455
Lihua Yao – Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis 55455, Minnesota
Paari Murugan – Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, Minnesota
Author Contributions
ISSN:0893-228X
1520-5010
DOI:10.1021/acs.chemrestox.2c00012